Rock Springs Capital Management LP

Insider Reports History

Location
Baltimore, MD
Signature
By: /s/ Mark Bussard, Authorized Signatory, Rock Springs Capital Management LP
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rock Springs Capital Management LP:

Company Role Class Num Shares Value Price $ Report Date Ownership
Theseus Pharmaceuticals, Inc. 10%+ Owner Common Stock 599,320 $1,827,926 $3.05 12 Oct 2021 Indirect
Verve Therapeutics, Inc. 10%+ Owner Common Stock 152,926 $1,529,260 $10.00 21 Jun 2021 Indirect
Xilio Therapeutics, Inc. 10%+ Owner Common Stock 1,256,472 $1,042,872 $0.8300 26 Oct 2021 Indirect
Tempest Therapeutics, Inc. 10%+ Owner Common Stock 73,654 $352,066 $4.78 30 Dec 2021 Indirect
Theseus Pharmaceuticals, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 12 Oct 2021 Indirect
Verve Therapeutics, Inc. 10%+ Owner Series B Preferred Stock 0 21 Jun 2021 Indirect
Xilio Therapeutics, Inc. 10%+ Owner Series C Preferred Stock 0 26 Oct 2021 Indirect

Insider Reports Filed by Rock Springs Capital Management LP

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TPST Tempest Therapeutics, Inc. 30 Dec 2021 0 $0 3 10%+ Owner 10 Jan 2022, 16:15
XLO Xilio Therapeutics, Inc. 26 Oct 2021 5 +$8,000,000 4 10%+ Owner 26 Oct 2021, 17:04
XLO Xilio Therapeutics, Inc. 21 Oct 2021 0 $0 3 10%+ Owner 21 Oct 2021, 20:51
/report/000089924321040255-rock-springs-capital-management-lp-2021-10-12 Theseus Pharmaceuticals, Inc. 12 Oct 2021 5 +$4,000,000 4 10%+ Owner 14 Oct 2021, 17:00
/report/000089924321039500-rock-springs-capital-management-lp-2021-10-06 Theseus Pharmaceuticals, Inc. 06 Oct 2021 0 $0 3 10%+ Owner 06 Oct 2021, 19:01
VERV Verve Therapeutics, Inc. 21 Jun 2021 5 +$7,030,000 4 10%+ Owner 22 Jun 2021, 17:20
VERV Verve Therapeutics, Inc. 16 Jun 2021 0 $0 3 10%+ Owner 16 Jun 2021, 19:15